NK cells play a crucial role in innate defense against pathogens such as murine cytomegalovirus (MCMV). The presence of both activating and inhibitory receptors on the surface of NK cells act collaboratively and in concert with innate cytokines to regulate NK cell functions. Recently, we showed that the killer cell lectin-like receptor G 1 (KLRG 1) is expressed on the most mature NK cells and that infection with MCMV induces an up-regulation of the KLRG1 molecule on the surface of both NK cells and CD8+ T cells. We also demonstrated that KLRG 1 engagement can inhibit NK cell effector functions. In addition, we generated the KLRG1 tetramer and have identified cell lines that are tetramer positive by flow cytometry. Based on these preliminary data, we therefore propose to study several aspects of KLRG 1 functions.
In Specific Aim 1, we will use KLRG 1 as a marker of mature NK cells to investigate the NK cell compartmental expansion and contraction phases in response to MCMV infection. We will also examine the consequences of the in vivo blocking of KLRG 1 functions in the context of the MCMV infection of mice in order to determine whether KLRG1 function is to prevent the uncontrolled activation of both NK cells and/or CD8 v T cells.
In Specific Aim 2, we will study the biochemical mechanism that dictates the inhibitory properties of the KLRG1 molecule. To do this, transfection/expression analyses of wild-type and mutant KLRG1 molecules will be performed.
In Specific Aim 3, we will use a reporter cell line approach, to both confirm the specificity of our tetramer staining and identify cells that express the KLRG1 ligand.
In Specific Aim 4, an expression cloning strategy will be developed to clone the KLRG1 ligand. These novel studies will provide insights into the specificity and immunoregulatory role of KLRG1 in particular and NK receptors in general on both NK cells and CD8+ T cells, as well as provide strategies for the regulation of this important category of immune cell responses.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Beisel, Christopher E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brown University
Schools of Medicine
United States
Zip Code
Banh, Cindy; Miah, S M Shahjahan; Kerr, William G et al. (2012) Mouse natural killer cell development and maturation are differentially regulated by SHIP-1. Blood 120:4583-90
Vivier, Eric; Ugolini, Sophie; Blaise, Didier et al. (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12:239-52
Tessmer, Marlowe S; Reilly, Emma C; Brossay, Laurent (2011) Salivary gland NK cells are phenotypically and functionally unique. PLoS Pathog 7:e1001254
Terrizzi, Stephanie C; Banh, Cindy; Brossay, Laurent (2010) A protocol for the production of KLRG1 tetramer. J Vis Exp :
Banh, Cindy; Fugere, Celine; Brossay, Laurent (2009) Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling. Blood 114:5299-306
Wesley, Johnna D; Tessmer, Marlowe S; Chaukos, Deanna et al. (2008) NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog 4:e1000106
Pilbeam, Kristy; Basse, Per; Brossay, Laurent et al. (2008) The ontogeny and fate of NK cells marked by permanent DNA rearrangements. J Immunol 180:1432-41
Chaix, Julie; Tessmer, Marlowe S; Hoebe, Kasper et al. (2008) Cutting edge: Priming of NK cells by IL-18. J Immunol 181:1627-31
Tessmer, Marlowe S; Fugere, Celine; Stevenaert, Frederik et al. (2007) KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol 19:391-400
Robbins, Scott H; Tessmer, Marlowe S; Van Kaer, Luc et al. (2005) Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Eur J Immunol 35:757-65